<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="4794">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01814202</url>
  </required_header>
  <id_info>
    <org_study_id>PTM.2012.002</org_study_id>
    <secondary_id>PR-13002</secondary_id>
    <nct_id>NCT01814202</nct_id>
  </id_info>
  <brief_title>Study With Medical Nutrition Product PTM202 in Pediatric Diarrhea</brief_title>
  <official_title>A Double-blind, Randomized, Placebo-controlled Clinical Trial (Pilot Phase) to Evaluate the Efficacy of a Medical Nutrition Product, PTM202, in Children With Acute Diarrhea</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>PanTheryx, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>PanTheryx, Inc.</source>
  <oversight_info>
    <authority>Bangladesh: Ethical Review Committee</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether a medical nutrition product, PTM202, along
      with standard of care, enhances recovery and reduces diarrhea morbidity in young children
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>March 2013</start_date>
  <completion_date type="Actual">September 2013</completion_date>
  <primary_completion_date type="Actual">September 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>diarrhea duration</measure>
    <time_frame>7 days</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>food intake</measure>
    <time_frame>7 days</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>stool frequency</measure>
    <time_frame>7 days</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>stool consistency</measure>
    <time_frame>7 days</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">68</enrollment>
  <condition>Acute Diarrhea</condition>
  <arm_group>
    <arm_group_label>PTM202</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>PTM202 is a medical nutrition product</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>The placebo is a placebo for PTM202, a food product that can not be distinguished from PTM202 by appearance, taste or odor</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>PTM202</intervention_name>
    <arm_group_label>PTM202</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  males or females between 6 months and 5 years of age

          -  acute diarrhea (&lt;48 hours) without interfering co-morbidities

          -  guardian willing to have child admitted to hospital as an inpatient for 96 hours and
             to return to the clinic with the child on Day 7 for a final evaluation

          -  Guardian is willing and able to report to the Investigator information on stool
             frequency, stool consistency and food and water intakes during the follow up phase.

          -  Written informed consent must be obtained prior to admission to this study.

          -  The subject has a physical examination that reveals no clinically significant
             abnormalities other than those expected for subjects with acute infectious diarrhea.

        Exclusion Criteria:

          -  Suspected or confirmed cholera

          -  Suspected dysentery

          -  Symptom duration &gt;48 hours at screening

          -  Vomiting severity that is like to make administration and retention of test article
             impossible

          -  Severe malnutrition (defined as weight for height of less than -3 SD below median,
             per WHO Standards (6).

          -  Child already receiving antibiotics or anti-motility drugs for this diarrhea episode
             prior to screening.

          -  History of hypersensitivity or allergy to milk or egg
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>6 Months</minimum_age>
    <maximum_age>5 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Shafiqul A Sarker, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>International Centre for Diarrhoeal Disease Research, Bangladesh</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b)</name>
      <address>
        <city>Dhaka</city>
        <zip>1212</zip>
        <country>Bangladesh</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Bangladesh</country>
  </location_countries>
  <verification_date>October 2013</verification_date>
  <lastchanged_date>October 4, 2013</lastchanged_date>
  <firstreceived_date>March 15, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Diarrhea</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
